Sydney B. Rosen - Epidemiology

Author Information

Sydney B. Rosen is affiliated with the Health Economics and Epidemiology Research Office, Wits Health Consortium, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand in Johannesburg, South Africa. Her research primarily focuses on public health issues, particularly in relation to HIV treatment and care, with a strong emphasis on the economic aspects of health interventions.

Research Contributions

Sydney B. Rosen has made significant contributions to the field of Epidemiology, particularly in the area of HIV treatment and care. Her recent work includes studies on the impact of the COVID-19 pandemic on HIV treatment initiation in South Africa, the effectiveness of multi-month dispensing of antiretroviral therapy in Malawi and Zambia, and the cost-outcomes of fast-track treatment initiation counseling in South Africa. She has also explored patient retention in care and viral suppression after same-day ART initiation, and has adapted WHO's tuberculosis patient cost instrument for longitudinal studies in Africa. Her research often combines clinical trials and economic evaluations to inform health policy and improve service delivery models for antiretroviral treatment.

Aliases

Sydney B. Rosen is also known by several aliases including S Rosen, S. Rosen, and Sydney Rosen.

Publication and Citation Metrics

Metric	Value
Citation Count	3507
h-index	29
Paper Count	110

Publications:

Reduction in initiations of HIV treatment in South Africa during the COVID pandemic

DOI: 10.1186/s12913-022-07714-y

Year: 2022

Multimonth dispensing of up to 6 months of antiretroviral therapy in Malawi and Zambia (INTERVAL): a cluster-randomised, non-blinded, non-inferiority trial.

DOI: 10.1016/S2214-109X(21)00039-5

Year: 2021

Fast-track treatment initiation counselling in South Africa: A cost-outcomes analysis

DOI: 10.1371/journal.pone.0248551

Year: 2021

Adaptation of WHO’s generic tuberculosis patient cost instrument for a longitudinal study in Africa

DOI: 10.1080/16549716.2020.1865625

Year: 2021

Retention in care and viral suppression after same‐day ART initiation: One‐year outcomes of the SLATE I and II individually randomized clinical trials in South Africa

DOI: 10.1002/jia2.25825

Year: 2021

Retention in care and viral suppression after same-day ART initiation: One-year outcomes of the SLATE I and II individually randomized clinical trials in South Africa

DOI: 10.1101/2021.06.11.21258784

Year: 2021

The revolving door of HIV care: Revising the service delivery cascade to achieve the UNAIDS 95-95-95 goals

DOI: 10.1371/journal.pmed.1003651

Year: 2021

Changes in HIV Treatment Differentiated Care Utilization During the COVID-19 Pandemic in Zambia

DOI: 10.1101/2021.03.20.21254021

Year: 2021

Economic evaluations of differentiated service delivery should include savings and ancillary benefits, not only health system costs: authors' reply.

DOI: 10.1097/QAD.0000000000003034

Year: 2021

How soon should patients be eligible for differentiated service delivery models for antiretroviral treatment? Evidence from Zambia

DOI: 10.1101/2021.08.25.21262587

Year: 2021

What is Universal Health Coverage (UHC)?

Why Are Falls and Injuries Important in Epidemiology?

How to Choose the Right Training Program?

How Can Healthcare Outcomes be Improved?

How Can Trust Be Restored?

What Challenges Exist in Studying Patients?

What Role Does Epidemiology Play in Promoting Healthy Lifestyles?

Why is Sampling Important?

What is Data Quality in Epidemiology?

Who Needs Access to These Tools?

Partnered Content Networks

Relevant Topics